Meliva Kardiolita Hospital
| Lituania | Turchia | Austria | |
| Trattamento farmacologico per la sclerosi multipla | - | da $2,500 | da $2,000 |
| Scambio di plasma | - | da $3,900 | - |
| Riabilitazione della sclerosi multipla | - | da $3,000 | da $10,000 |
| Plasmaferesi | - | da $1,200 | da $2,000 |
| Ocrevus (ocrelizumab) | - | da $10,000 | da $35,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Sclerosi multipla. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Sclerosi multipla e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Sclerosi multipla.
Lithuania's leading centers for multiple sclerosis treatment include Vilnius University Hospital Santaros Klinikos and Kaunas Clinics. These academic institutions manage the national MS registry. Leading private options like Meliva Kardiolita Hospital and Medical Diagnostic and Treatment Center provide rapid diagnostics and specialized rehabilitation services.
Bookimed Expert Insight: While public university hospitals hold the national registry, private centers in Vilnius offer a significant speed advantage. Medical Diagnostic and Treatment Center reports that 10% of their 48,000 annual patients arrive from abroad. This high international volume suggests these facilities have streamlined logistics for non-residents that public centers may lack.
Patient Consensus: Patients note that Santaros Klinikos is the main provider for complex therapies but advise preparing for wait times of several months. Many recommend using private clinics for faster MRI scans and initial neurology consultations to avoid delays in starting treatment.
Lithuania provides a comprehensive range of disease-modifying therapies (DMTs) for multiple sclerosis, including first-line injectables and high-efficacy infusions. Treatment spans platform therapies like Interferon beta-1a to advanced options such as Ocrelizumab. National health regulations and European Union standards govern availability within JCI-accredited facilities.
Bookimed Expert Insight: While Lithuania offers the same MS drug catalog as Western Europe, the clinical pathway is strictly tiered. Private centers like Meliva Kardiolita Hospital or the Medical Diagnostic and Treatment Center serve over 350,000 patients combined yearly. These high-volume centers prioritize rapid diagnostic staging, which is essential because high-efficacy DMTs usually require an EDSS score below 6.0 for approval.
Patient Consensus: Patients note that while the latest drugs are technically available, the approval process through the national health fund often requires documented proof of relapses. Many recommend preparing detailed medical records early to avoid delays when switching from platform therapies to high-efficacy infusions.
Lithuania fully reimburses Multiple Sclerosis (MS) prescription medications included in its List A registry. The Compulsory Health Insurance Fund covers 100% of the base price for insured residents. Patients may only pay a small premium if they choose higher-priced brand names over generics.
Bookimed Expert Insight: Data from major Vilnius centers like Meliva Kardiolita Hospital and Medical Diagnostic and Treatment Center show a heavy focus on diagnostics. While the state covers many drugs, the approval process for modern monoclonal antibodies often requires documented failure of older therapies. Choosing a facility with over 200 specialists can help expedite the complex documentation needed for these high-tier reimbursement appeals.
Patient Consensus: Patients note that while basic drugs are easily accessed, switching to newer treatments can involve long paperwork delays. Many emphasize that keeping detailed records of MRI changes and relapses is vital for getting state approval for advanced biologics.
Private medical insurance is highly recommended for multiple sclerosis care in Lithuania to bypass public health wait times. While the national system covers basic treatments, neurologist shortages can delay appointments by 3 to 6 months. Private coverage ensures diagnostic access, like MRI scans, within 1 week instead of months.
Bookimed Expert Insight: Clinical data shows a major capacity gap between public and private sectors in Vilnius. Meliva Kardiolita Hospital treats 298,000 patients annually and maintains 33 specialized departments. This high volume suggests that private facilities are better equipped to handle complex diagnostic needs quickly. For chronic conditions like multiple sclerosis, choosing a clinic with high patient turnover ensures access to experienced specialists and modern infrastructure.
Patient Consensus: Patients emphasize that while the public system provides basic medications, the bureaucracy and long queues make private insurance essential. Many suggest securing an add-on policy early to ensure quick access during sudden flares or relapses.
Specialized neurological rehabilitation for multiple sclerosis is accessible in Lithuania through JCI-accredited hospitals and dedicated centers. Facilities offer multidisciplinary care including kinesiotherapy, hydrotherapy, and plasmapheresis. Treatment centers in Vilnius and Kaunas combine pharmacological management with physical medicine to improve patient mobility and cognitive function.
Bookimed Expert Insight: While public systems have longer waitlists, Lithuania's private sector is specifically designed for high-speed access. Meliva Kardiolita Hospital serves 298,000 patients annually and maintains 33 specialized departments. This scale allows international patients to bypass the typical 6-month wait times found in regional public neuro-rehab programs. Choosing a private center in Vilnius often ensures immediate access to both neurologists and intensive daily rehabilitation sessions.
Patient Consensus: Patients note that while basic physiotherapy is standard, private facilities offer better access to supplemental care like cognitive behavioral therapy. Some individuals navigate waitlists by utilizing private centers that specialize in fast-track recovery plans for international visitors.
Recognised Multiple Sclerosis specialists in Lithuania are primarily neurologists and neuroimmunologists practicing at major university centers. Patients can access care through the public system at Vilnius University Hospital or private facilities like Meliva Kardiolita Hospital and Medical Diagnostic and Treatment Center. A GP referral is required for public consultations.
Bookimed Expert Insight: While private centers like Meliva Kardiolita or Medical Diagnostic and Treatment Center offer faster diagnostic sessions, the Lithuanian public system centralizes most high-cost disease-modifying therapies. Patients often use private clinics for rapid initial MRI scans and second opinions before transitioning to university hospitals for long-term pharmaceutical management. This hybrid approach reduces waiting times during the critical early diagnosis phase.
Patient Consensus: Patients note that finding a neurologist specifically focused on neuroimmunology is vital since general neurology training varies. Many suggest connecting with local MS organizations for informal specialist recommendations and travel to Poland if seeking additional treatment options.
Private facilities in Lithuania provide high-resolution 3 Tesla MRI scans crucial for detecting multiple sclerosis lesions. Leading centers like Medical Diagnostic and Treatment Center and Meliva Kardiolita Hospital offer rapid access to neuroimaging. These JCI-accredited institutions ensure diagnostic accuracy using advanced Siemens and GE technology.
Bookimed Expert Insight: A major advantage in Lithuania is the concentration of multi-specialty expertise in Vilnius. Medical Diagnostic and Treatment Center integrates 53 departments under one roof. This allows for immediate neurological consultation following an MRI. This efficiency is rare compared to smaller diagnostic-only clinics. It significantly reduces the time from initial scan to a confirmed treatment plan.
Patient Consensus: Patients note that private clinics like Kardiolita are the top choice for avoiding long public waitlists. They emphasize that while some smaller centers have minor language barriers, the large hospital chains provide seamless multilingual support.
Lithuania provides autologous haematopoietic stem cell transplantation (AHSCT) for multiple sclerosis as a routine clinical treatment. Major Vilnius-based centres follow protocols from the European Society for Blood and Marrow Transplantation (EBMT). The procedure targets patients with highly active relapsing-remitting multiple sclerosis who do not respond to standard therapies.
Bookimed Expert Insight: Public hospitals like Santaros Klinikos handle the complex AHSCT procedure. Private facilities in Vilnius excel at the necessary post-transplant rehabilitation. Meliva Kardiolita Hospital treats nearly 300,000 patients annually and specifically welcomes Australians. This high patient volume often means better infrastructure for international visitors needing long-term recovery support.
Patient Consensus: Patients note it is important to confirm whether the procedure is self-funded or part of a trial. Researching specific hospitals in Vilnius helps verify if the treatment is available for a specific MS subtype.
Lithuania provides a full range of modern disease-modifying therapies (DMTs) for multiple sclerosis. Facilities comply with European Union medical standards. Patients can access high-efficacy infusions and oral medications. Specialists use a national registry to track outcomes. This helps with early intervention for better long-term progression management.
Bookimed Expert Insight: Lithuania functions as a hub for international patients from Australia and Europe. Meliva Kardiolita Hospital alone serves approximately 298,000 patients annually. This volume across 33 specialised departments suggests Lithuanian neurologists maintain high clinical proficiency. They are experienced in managing complex, long-term medication protocols.
Patient Consensus: Patients note it is important to verify drug names with Lithuanian specialists before travelling. They suggest confirming if local follow-up care or remote monitoring can be organised. This should be arranged before returning to Australia.
Australian patients can access specialised multiple sclerosis treatment at JCI-accredited facilities in Vilnius and Kaunas. Major centres like Meliva Kardiolita Hospital and the Medical Diagnostic and Treatment Center provide neurology services. These institutions offer modern diagnostics and rehabilitation in English-speaking environments.
Bookimed Expert Insight: Patient volume data suggests Lithuania is a significant hub for private neurology. Meliva Kardiolita alone treats 298,000 patients annually. For Australians, this suggests a highly efficient system. Specialists here often manage complex international cases with minimal waiting times.
Patient Consensus: Patients note the importance of coordinating overseas treatment plans with their Australian neurologist. They often request imaging reports in English for smooth continuity of care after returning home.
Obtaining a multiple sclerosis diagnosis or second opinion in Lithuania involves consulting specialists in Vilnius at JCI-accredited centres. Patients undergo clinical assessments, high-resolution MRI scans, and lumbar punctures to confirm findings. Private hospitals such as Meliva Kardiolita Hospital providing quick access to neurology specialists and neuroimaging.
Bookimed Expert Insight: Bookimed data shows Lithuanian private centres operate with significant scale. Meliva Kardiolita Hospital serves 298,000 patients annually and holds JCI accreditation. This high patient volume often leads to faster diagnostics than the public system. Australian patients can find specialists there who are accustomed to international cases and providing detailed English-language reports.
Lithuania offers no formal patient support groups specifically for Australians travelling for multiple sclerosis care. Travellers primarily use the Lithuanian MS Society for local resources. International networks like the Multiple Sclerosis International Federation connect patients globally. Major Vilnius clinics provide JCI-accredited infrastructure for neurological rehabilitation.
Bookimed Expert Insight: Dedicated travel groups are rare, but clinic scale often dictates the support level. Kardiolita Hospital in Vilnius manages nearly 300,000 patients yearly. It explicitly caters to Australians. Choosing high-volume centres means administrative staff are accustomed to coordinating logistics that support groups usually discuss.
Patient Consensus: Patients note peer support for Lithuania remains informal. Many emphasise coordinating MRI transfers. They also recommend confirming if Australian GPs will manage follow-up care before departing.